REHAB Basel investigates how end-effector gait therapy using the THERA-Trainer lyra affects walking ability in patients with incomplete paraplegia. The pilot study compares outcomes with conventional rehabilitation and evaluates feasibility in clinical settings.
Gait rehabilitation plays an important role in restoring the ability of patients with incomplete paraplegia to stand and walk. REHAB Basel, a clinic for neurorehabilitation and paraplegiology, has been using the THERA-Trainer lyra intensively since 2015 to treat and improve patient walking ability. REHAB Basel is increasingly using the end-effector gait trainer as part of a training concept in combination with other devices, particularly for inpatient therapy. In 2016, patients completed almost 500 training sessions.
In a pilot study at REHAB Basel, the effects of device-supported end-effector therapy on patients with incomplete paraplegia are currently being investigated and compared to the outcomes of conventional rehabilitation methods. The physiotherapy department has been using a THERA-Trainer lyra for this since January 2017. It is assumed that both forms of therapy lead to an improvement in walking ability and the aids needed, with device-based therapy expected to have greater success in improving walking speed. Another important point of the study is the evaluation of the feasibility of systematic gait training in a clinical setting.
Related contents
Find related exciting contents in our media library.
Meet our specialists.
Are you interested in our solutions? Schedule a meeting with a Consultant to talk through your strategy and understand how TEHRA-Trainer can help you to advance rehabilitation.
You need to load content from reCAPTCHA to submit the form. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from Turnstile. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More Information